Home  >  Products  >  POF1B (premature ovarian failure, 1B ) Blocking Peptide (the N terminal of POF1B)(100ug)
POF1B (premature ovarian failure, 1B ) Blocking Peptide (the N terminal of POF1B)(100ug)

POF1B (premature ovarian failure, 1B ) Blocking Peptide (the N terminal of POF1B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-POF1B Antibody (ARP66639_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP66639
Size: 100ug
Weight: 65kDa
Gene: 79983
Format: Lyophilized powder
Target: Premature ovarian failure (POF) is characterized by primary or secondary amenorrhea in women less than 40 years old. Two POF susceptibility regions called 'POF1' and 'POF2' have been identified by breakpoint mapping of X-autosome translocations. POF1 extends from Xq21-qter while POF2 extends from Xq13.3 to Xq21.1. This gene, POF1B, resides in the POF2 region. This gene is expressed at trace levels in mouse prenatal ovary and is barely detectable or absent from adult ovary, in human and in the mouse respectively. This gene's expression is restricted to epithelia with its highest expression in the epidermis, and oro-pharyngeal and gastro-intestinal tracts. The protein encoded by this gene binds non-muscle actin filaments. The role this gene may play in the etiology of premature ovarian failure remains to be determined.
Alternative names: FLJ22792; POF; POF2B
See Full Product Listings >